Hydralazine Hydrochloride Injection
Product Images NDC 70518-3659

4 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 70518-3659). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Hyd0r 0001 01)

Structure (Hyd0r 0001 01)
Chemical structure of hydrALAZINE Hydrochloride, showing its molecular formula (C8H8N4 · HCl) and molecular weight (196.64). The structure includes a bicyclic ring system with hydrazine and hydrochloride components.*
FDA Label Image

Mm1 (Hydralazine HCl 20mg mL 70518 3659 00)

Mm1 (Hydralazine HCl 20mg  mL 70518 3659 00)
Label for hydrALAZINE Hydrochloride Injection 20 mg/mL in 1 mL single-dose vials, quantity 25. The product is for intramuscular or intravenous use and is repackaged by RemedyRepack Inc., Indiana, PA. The label includes storage instructions and a warning for emergency use only in patients unable to take oral medication.*
FDA Label Image

Mm2 (Hydralazine HCl 20mg mL 70518 3659 01)

Mm2 (Hydralazine HCl 20mg  mL 70518 3659 01)
Label for hydrALAZINE Hydrochloride Injection 20 mg/mL in single-dose 1 mL vials, packaged 25 vials per quantity. The injection is for intramuscular or intravenous use. The label shows the product NDC 70518-3659-01 and is repackaged by RemedyRepack Inc., Indiana, PA. Storage instructions indicate keeping the product between 20-25°C with allowed excursions. Manufacturer is Fresenius Kabi, Lake Zurich, IL.*
FDA Label Image

Mm3 (Hydralazine HCl 20mg mL 70518 3659 02)

Mm3 (Hydralazine HCl 20mg  mL 70518 3659 02)
Label for hydrALAZINE Hydrochloride 20 mg/mL injection, 1 mL single-dose vial. The label indicates it is intended for intramuscular or intravenous use, labeled RX only. The product is repackaged by RemedyRepack Inc. with manufacturing by Fresenius Kabi, Lake Zurich, IL. The label includes NDC 70518-3659-02 and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.